ÂÜÀòÂÒÂ×

Kristin has more than 25 years of experience in the biopharmaceutical industry, with a proven track record of successfully leading global clinical programs across all phases of development. Prior to Syros, Kristin spent nearly 10 years at Millennium Pharmaceuticals and then Takeda Pharmaceuticals in a variety of roles with escalating responsibilities, serving most recently as Vice President of Global Clinical Operations. In that role, she led more than 50 concurrent clinical studies across 15 programs and managed a functional team of more than 100 people across the United States, Europe, and Asia. Kristin played an instrumental in the development and ultimate approval of ENTYVIO for inflammatory bowel disease and NINLARO for hematologic malignancies. Earlier in her career, Kristin worked at Quintiles Strategic Research Services, Clinical Assistance Programs, and Eastern Cooperative Oncology Group. Kristin earned her B.A. in mathematics and psychology at William Smith College.